ReviewMicroorganisms2025
Bacteriophage Therapy in Freshwater and Saltwater Aquaculture Species.
Review in Microorganisms, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Bacteriophages AgainstViruses · 2026Review
- Article
- Targeted isolation of TolC-dependent phages reveals dual strategies for combating multidrug-resistant avianFrontiers in microbiology · 2026Article
- High-level multidrug resistance and an unexpected mecA gene detection in Vibrio spp. from Litopenaeus vannamei aquaculture in Vietnam.International microbiology : the official journal of the Spanish Society for Microbiology · 2025Article
- Isolation and characterization of bacteriophages with lytic activity against multidrug-resistant non-typhoidal Salmonella from Nairobi City county, Kenya.BMC infectious diseases · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Bacteriophages, or phages, which are viruses with specifically restricted tropism for bacteria, have regained interest in the last few decades as alternative therapeutic agents against antibiotic-resistant pathogenic bacteria in animals and humans worldwide. In this context, bacteriophage therapy has been developed to treat bacterial infections of cultured fish, shellfish, and crustaceans. Nowadays, aquaculture is the only feasible solution to meet the continuously growing global demand for high-quality seafood. As such, it is crucial to focus on controlling the spread of pathogenic bacteria, as they have a significant economic impact on aquaculture systems. Overall, the documented research supports the application of bacteriophage therapy in aquaculture, but also underlies the need for additional studies, as it is still mostly in the scientific stage. This review aims to highlight and critically examine recent advancements in the application of bacteriophages to treat the most common bacterial infectious diseases in both freshwater and saltwater aquaculture species, providing topical perspectives and innovative advances.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.